✉news WorldEU Politics first seen 1 d ago, last 1 d ago, peak #33

Eli Lilly Rises 4% as Foundayo Nears European Approval

Original: Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher

Eli Lilly shares rose about 4%, with Amgen and Novo Nordisk also edging higher, while Foundayo moved closer to European regulatory approval. The moves point to renewed investor interest in pharmaceutical stocks, particularly around obesity and metabolic drug developers, as companies approach key regulatory milestones in Europe.

Why now: Positive share moves and a looming European approval are drawing investor attention to major pharma names.

Eli LillyFoundayoAmgenNovo Nordisk

Open on news →

Evidence

• Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher · 24/7 Wall St.

API: https://socialmediatrends-api.osmike.com/v1/trends/3013445